Molecular screening of the cyp4v2 gene in Bietti crystalline dystrophy that is associated with Choroidal neovascularization

Molecular Vision

Volumn 17, Issue , 2011, Pages 1970-1977

  Mamatha, Gandra ^a   Umashankar, Vetrivel ^a   Kasinathan, Nachiappan ^b   Krishnan, Tandava ^b   Sathyabaarathi, Ravichandran ^a   Karthiyayini, Thirumalai ^a   Amali, John ^a   Rao, Chetan ^b   Madhavan, Jagadeesan ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b MEDICAL RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BIETTI CRYSTALLINE DYSTROPHY; CASE REPORT; CLINICAL FEATURE; CYP4V2 GENE; FEMALE; GENE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; LEUKOCYTE; MALE; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OPHTHALMOSCOPY; PIGMENT EPITHELIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; SUBRETINAL NEOVASCULARIZATION; TIMP3 GENE; VISUAL ACUITY;

ASIAN CONTINENTAL ANCESTRY GROUP; CHOROIDAL NEOVASCULARIZATION; COHORT STUDIES; CORNEAL DYSTROPHIES, HEREDITARY; CYTOCHROME P-450 ENZYME SYSTEM; DNA MUTATIONAL ANALYSIS; ELECTRORETINOGRAPHY; EXONS; GENES, RECESSIVE; GENETIC TESTING; HUMANS; INDIA; MODELS, MOLECULAR; MUTATION; PEDIGREE; POLYMERASE CHAIN REACTION; RETINAL DISEASES; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 79960719837     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hu DN. Prevalence and mode of inheritance of major genetic eye diseases in China. J Med Genet 1987; 24:584-8.
2. Li A, Jiao X, Munier FL, Schorderet DF, Yao W, Iwata F, Hayakawa M, Kanai A, Shy Chen M, Alan Lewis R, Heckenlively J, Weleber RG, Traboulsi EI, Zhang Q, Xiao X, Kaiser-Kupfer M, Sergeev YV, Hejtmancik JF. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet 2004; 74:817-26.
3. Lee J, Jiao X, Hejtmancik JF, Kaiser-Kupfer M, Gahl WA, Markello TC, Guo J, Chader GJ. The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci 2001; 42:1707-14.
4. Wilson DJ, Weleber RG, Klein ML, Welch RB, Green WR. Bietti's Crystalline Dystrophy: A Clinicopathologic Correlative Study. Arch Ophthalmol 1989; 107:213-21.
5. Qi JH, Dai G, Luthert P, Chaurasia S, Hollyfield J, Weber BH, Stöhr H, Anand-Apte B. S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis. J Biol Chem 2009; 284:19927-36.
6. Le Tien V, Atmani K, Querques G, Massamba N, Souied EH. Ranibizumab for subfoveal choroidal neovascularization in Bietti crystalline retinopathy. Eye (Lond) 2010; 24:1728-9.
7. Atmaca LS, Muftuoglu O, Atmaca-Sonmez P. Peripapillary choroidal neovascularization in Bietti crystalline retinopathy. Eye (Lond) 2007; 21:839-42.
8. Gupta B, Parvizi S, Mohamed MD. Bietti crystalline dystrophy and choroidal neovascularisation. Int Ophthalmol 2011; 31:59-61.
9. Fiser A, Sali A. Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 2003; 374:461-91.
10. Summa CM, Levitt M. Near-native structure refinement using in vacuo energy minimization. Proc Natl Acad Sci USA 2007; 104:3177-82.
11. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 1996; 8:477-86.
12. Wallner B, Elofsson A. Can correct protein models be identified? Protein Sci 2003; 12:1073-86.
13. Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res 2010; 38:W529-33.
14. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-80.
15. Henikoff S, Henikoff JG. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992; 89:10915-9.
16. Gromiha MM. A statistical model for predicting protein folding rates from amino acid sequence with structural class information. J Chem Inf Model 2005; 45:494-501.
17. Shen B, Vihinen M. RankViaContact: ranking and visualization of amino acid contacts. Bioinformatics 2003; 19:2161-2.
18. Heinig M, Frishman D. STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins. Nucleic Acids Res 2004; 32:W500-2.
19. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 2001; 98:10037-41.
20. Guymer RH, Héon E, Lotery AJ, Munier FL, Schorderet DF, Baird PN, McNeil RJ, Haines H, Sheffield VC, Stone EM. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 2001; 119:745-51.
21. Leu J, Schrage NF, Degenring RF. Choroidal neovascularisation secondary to Best's disease in a 13-yearold boy treated by intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol 2007; 245:1723-5.
22. Rhee DY, Reichel E, Rogers A, Strominger M. Subfoveal choroidal neovascularization in a 3-year-old child with North Carolina macular dystrophy. J AAPOS 2007; 11:614-5.